Consultation on NHS funding of ‘low priority’ items

Consultation on NHS funding of ‘low priority’ items

November 28, 2018

NHS England has today (28th November) published a consultation on proposals to extend the list of products that primary care prescribers are recommended not to routinely prescribe.

The consultation follows the agreement of the proposals by the NHS England Board this morning. The intention is to update the November 2017 national guidance for clinical commissioning groups (CCGs) on Items which should not to be routinely prescribed in primary care.

Following a review of the CCG guidance by a clinical working group, views are now being sought on adding a list of eight products/types of products which are considered to be of ‘low priority’ for NHS funding.

Items considered to be of low clinical effectiveness:

  • Amiodarone
  • Emollient bath and shower preparations for dry and pruritic skin conditions
  • Dronedarone
  • Minocycline for acne
  • Silk garments

Items where more cost-effective products are readily available:

  • Aliskiren
  • Blood glucose testing strips for people with type 2 diabetes that cost >£10 for 50 strips
  • Needles for pre-filled and reusable insulin pens that cost >£5 per 100 needles

In its proposals, NHS England has recognised the need to take account of clinical exceptions in limiting the prescribing of these products. The Board was also keen to make clear that the proposals for the second group do not amount to a ban on prescribing, but rather focus on encouraging prescribers to choose lower cost items by introducing a recommended upper cost limit.

A further proposal is to update the current recommendations on rubefacients to exclude capsaicin cream, as this product falls within guidance from the National Institute for Health and Care Excellence (NICE).

Interested parties have until 28th February 2019 to respond via the public consultation on the NHS England website.

 



Posted in: , ,


More Latest News >

NUMSAS: are you claiming correctly?

Following the extension of the NHS Urgent Medicine Supply Advanced Service (NUMSAS) pilot until September 30th 2019, community pharmacy contractors...

DHSC EU Exit Communication

Community pharmacy teams will be aware that Government has agreed a further extension of the EU exit date to 31st...

Shortage of Labetalol tablets

Specialist Pharmacy Service (SPS) advises that there is currently a shortage of Labetalol 50mg, 100mg, 200mg and 400mg tablets. The...